Replies to post #35958 on Biotech Values

[mblimon]

Coincidence or not, the CEO of AM-Pharma, Bruno Giannetti, will be the new COO of Pharming as from December 1st. I am pretty sure that Pharming will want to draw on his sepsis experience, since sepsis is also one of the potential indications for Rhucin (rhC1inh), Pharming's lead product.